“Neurotransmitters in the TME: Can Dopamine and Glutamate Be the Next Cancer Targets?”. Journal of Biomolecules, Pathogenesis and Therapeutics, vol. 2, no. 3, Sept. 2026, pp. 111-2, https://doi.org/10.68041/jbpt.v2i3/01.